Showing results (41-50 of 152) with videos related to

Sort By:
Pageof 16
Advances in Therapy|October 18, 2018
Cost-Effectiveness Analysis of Bezlotoxumab Added to Standard of Care Versus Standard of Care Alone for the Prevention of Recurrent Clostridium difficile Infection in High-Risk Patients in SpainMiguel Salavert, Javier Cobo, Álvaro Pascual, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|October 29, 2025
Legends, dogmas, presumptions, and demystifications in antibiotic therapyRosa Blanes Hernández, Santiago de Cossio Tejido, Francesc Puchades Gimeno, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|February 10, 2007
[Guidelines for the diagnosis and treatment of patients with bacteriemia. Guidelines of the Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica]José Miguel Cisneros-Herreros, Javier Cobo-Reinoso, Miquel Pujol-Rojo, et al.
Therapeutics and Clinical Risk Management|March 25, 2008
Voriconazole in the management of nosocomial invasive fungal infectionsJavier Pemán, Miguel Salavert, Emilia Cantón, et al.
Mycoses|March 3, 2016
Candidemia in major burns patientsAna I Renau Escrig, Miguel Salavert, Carmen Vivó, et al.
Jac-Antimicrobial Resistance|December 26, 2022
Dalbavancin in clinical practice in Spain: a 2 year retrospective studyLaura Morata, José María Aguado, Miguel Salavert, et al.
Frontiers in Pharmacology|March 17, 2025
Effectiveness of pharmacological treatments for COVID-19 due to SARS-CoV-2: a systematic literature reviewCarolina Garcia Vidal, Jonathan González, Carlos Lumbreras, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|December 6, 2005
[Streptococcal toxic shock syndrome: ten years' experience at a tertiary hospital]Manuel Vallalta-Morales, Miguel Salavert-Lletí, Arturo Artero-Mora, et al.
Journal of Medical Economics|March 28, 2017
Cost-effectiveness analysis of implementing an antimicrobial stewardship program in critical care unitsJesus Ruiz-Ramos, Juan Frasquet, Eva Romá, et al.
Therapeutics and Clinical Risk Management|April 2, 2009
Multidisciplinary approach to the treatment of invasive fungal infections in adult patients. Prophylaxis, empirical, preemptive or targeted therapy, which is the best in the different hosts?Rafael Zaragoza, Javier Pemán, Miguel Salavert, et al.
Pageof 16